Published in Drug Week, June 9th, 2006
In a recent report published in the journal Investigative Ophthalmology & Visual Science, researchers in the United States conducted a study to "examine whether human T-cell leukemia virus type 1 (HTLV-1) could infect a human retinal pigment epithelial (RPE) cell Line, ARPE-19, in vitro and to investigate its regulation.
"A coculture system with ARPE-19 and irradiated cells of an HTLV-1-producing T-cell line, MT2 was used to determine the permissivity of RPE to HTLV-I infection in vitro."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.